- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03428386
Single-Anastomosis Plication Ileal Bypass for Morbid Obesity
February 8, 2018 updated by: Sameh Emile, Mansoura University
Single-Anastomosis Plication Ileal Bypass in Treatment of Morbid Obesity: a Pilot Study
The present study aims to explore the impact of combining laparoscopic greater curvature plication with a single gastro-ileal anastomosis in the same manner of single anastomosis sleeve ileal bypass on weight loss and postoperative complications.
The objective of this combined procedure is to reduce the high intraluminal pressure that results after laparoscopic greater curvature plication owing to reduced intraluminal space which can lead to suture line leakage, vomiting, and gastroesophageal reflux disease.
Another objective is to add a malabsorptive element to the restrictive effect of laparoscopic greater curvature plication and to induce early satiety in patients by distention of the distal bowel with nutrients immediately after meals, similar to the way that single anastomosis sleeve ileal bypass works.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The present study aims to explore the impact of combining laparoscopic greater curvature plication with a single gastro-ileal anastomosis in the same manner of single anastomosis sleeve ileal bypass on weight loss and postoperative complications.
The objective of this combined procedure is to reduce the high intraluminal pressure that results after laparoscopic greater curvature plication owing to reduced intraluminal space which can lead to suture line leakage, vomiting, and gastroesophageal reflux disease.
Another objective is to add a malabsorptive element to the restrictive effect of laparoscopic greater curvature plication and to induce early satiety in patients by distention of the distal bowel with nutrients immediately after meals, similar to the way that single anastomosis sleeve ileal bypass works.
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sameh H Emile
- Email: sameh200@hotmail.com
Study Locations
-
-
Dakahlia
-
Mansourah, Dakahlia, Egypt
- Recruiting
- Mansoura University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 60 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult patients of both genders aging between 18 and 60 years with morbid obesity will be included to the study
Exclusion Criteria:
- Patients with secondary obesity due to endocrine disorders
- patient unfit for general anesthesia.
- patients who had not attempted non-surgical weight loss treatment in the past
- patients with psychological conditions that influence his/her perception of the study protocol
- patients with previous surgery for morbid obesity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Gastric plication ileal bypass
single-anastomosis plication ileal bypass
|
laparoscopic plication of the greater curvature of the stomach then the duodeno-jejunal junction is identified and 300 cm is measured downwards.
The selected loop will be ascended without division of the greater omentum, and a stapled isoperistaltic side-to-side to the anterior wall of the antrum of the stomach just 3 cm away from the pylorus with a linear stapler charged with a green cartridge, the diameter of ileal antrum anastomosis is not exceeding 3 cm in diameter.
The staple defect is closed with a two-layer running 3/0 polyglactin suture
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
weight loss
Time Frame: 6 months
|
Percentage of excess weight loss at 6 months after the procedure
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sameh H Emile, M.D., Mansoura University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2018
Primary Completion (Anticipated)
January 31, 2019
Study Completion (Anticipated)
May 30, 2019
Study Registration Dates
First Submitted
February 4, 2018
First Submitted That Met QC Criteria
February 8, 2018
First Posted (Actual)
February 9, 2018
Study Record Updates
Last Update Posted (Actual)
February 9, 2018
Last Update Submitted That Met QC Criteria
February 8, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- mansourau46
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Morbid Obesity
-
ClinTrio Ltd.UnknownMorbid Obesity Requiring Bariatric SurgeryBelgium, Germany, Portugal, Austria, Netherlands, Poland, Saudi Arabia
-
Centre Hospitalier Universitaire de NiceCompletedMorbid Obesity D009765France
-
Shanghai Jiao Tong University School of MedicineUnknown
-
Hospices Civils de LyonCentre de Recherche en Nutrition Humaine Rhone-Alpe; Institut National de Recherche... and other collaboratorsRecruiting
-
Endolumik, IncWest Virginia UniversityNot yet recruitingMorbid ObesityUnited States
-
Rijnstate HospitalRecruiting
-
Laval UniversityCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie...Recruiting
-
University of WashingtonUnited States Department of DefenseWithdrawn
-
Helsinki University Central HospitalActive, not recruiting
-
IHU StrasbourgWithdrawnMorbid Obesity
Clinical Trials on Gastric plication ileal bypass
-
Baystate Medical CenterTerminatedMorbid ObesityUnited States
-
Aleris HospitalActive, not recruitingPostoperative Complications | Metabolic Syndrome | Obesity, Morbid | Bariatric Surgery CandidateNorway
-
Assistance Publique Hopitaux De MarseilleUnknownMorbid Obesity | Bariatric SurgeryFrance
-
Hospital Sirio-LibanesCompletedObesity | Type 2 Diabetes MellitusBrazil
-
Ponce, Jaime, M.D.CompletedMorbid ObesityUnited States
-
Tenet Healthcare CorporationUnknown
-
The Hospital of VestfoldUniversity of OsloEnrolling by invitation
-
Virginia Commonwealth UniversityChildren's Hospital of RichmondCompletedObesityUnited States
-
University of California, San FranciscoWithdrawnWeight Loss | Morbid Obesity | Complex Incisional HerniasUnited States
-
Hospices Civils de LyonActive, not recruitingObesity, MorbidFrance